Daniel J. Becker, Director, 10% Owner at Pandion Therapeutics, Inc. (PAND), bought 2,601,773 shares at $18.00 ($13.0M) on 2020-07-21, disclosed to the SEC on 2020-07-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,878,551 | $0 | 0.0% |
| 2 | $18.00 | 1,000 | $18K | 0.1% |
| 3 | $18.00 | 722,222 | $13.0M | 99.9% |
| Total | $5.00 avg | 2,601,773 | $13.0M | 100% |
| Filing → |
| DAWN | BUY | 2021-06-01 | $80K | — | Filing → |
| PAND | BUY | 2020-11-23 | $6.0M | — | Filing → |
| PAND | BUY | 2020-11-19 | $867K | — | Filing → |